Educational purposes only. Not investment advice. Past performance does not guarantee future results. View full terms

MRK

Merck & Co., Inc. β€’ Healthcare (#5 of 11)

$120.84
+0.55 (+0.46%)
View:
Close:$120.84
Vol:LOW(0%ile)
Ratio:0.55x
|
RSI:61(Neutral)
MACD:↑
β‰₯75%25-75%<25%
Vol.%
Sector Rotation
2026-04-01(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRAL
β–²0 Upβ–Ό0 Down3 Hold
Mar 30RBC Capital
–Outperform
Mar 20Citigroup
–Neutral
Mar 12Wells Fargo
–Overweight
Price Targets
(60d mean: $132, +9.6%)
NEUTRAL
β–²2 Raisesβ–Ό0 Lowers+7.6% avg
Mar 30RBC Capital
$142β†’$142New
Mar 20Citigroup
$120β†’$125+4.2%
Mar 12Wells Fargo
$135β†’$150+11.1%
Trade Setup
Entry$120.84
Target$126.29 (+4.5%)
Stop$115.39
R/R1.00
Risk-4.5%
Conv37 (LOW)
Size81 shares ($9,788)
Risk Metrics
Sharpe (20d)
0.85Moderate
Volatility (20d)
20.2%Low
Beta (60d)
0.24Defensive
Alpha (20d)
+5.4%Strong
News Analysis
EN
δΈ­
ν•œ
ζ—₯

No analysis record found.